#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Correction: Intraperitoneal administration of follistatin promotes adipocyte browning in high-fat diet-induced obese mice


Authors: Haoyu Li;  Chuanhai Zhang;  Junyu Liu;  Wenya Xie;  Wentao Xu;  Fei Liang;  Kunlun Huang;  Xiaoyun He
Published in the journal: PLoS ONE 14(12)
Category: Correction
doi: https://doi.org/10.1371/journal.pone.0226344

The authors acknowledge the following incorrectly duplicated references:

Reference [3] also appears as reference [31]. The reference is: Nedergaard J, Bengtsson T, Cannon B. New Powers of Brown Fat: Fighting the Metabolic Syndrome. Cell Metabolism. 2011;13(3):238–40.

Reference [9] also appears as references [16] and [26]. The reference is: Singh R, Braga M, Reddy ST, Lee SJ, Parveen M, Grijalva V, et al. Follistatin targets distinct pathways to promote brown adipocyte characteristics in brown and white adipose tissues. Endocrinology. 2017;158(5):1217–30.

Reference [12] also appears as reference [24]. The reference is: Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. The FASEB Journal. 2013;27(5):1981–9.

Reference [11] also appears as reference [35]. The reference is: Braga M, Pervin S, Norris K, Bhasin S, Singh R. Inhibition of in vitro and in vivo brown fat differentiation program by myostatin. Obesity. 2013;21(6):1180–8.

Reference [15] also appears as reference [20]. The reference is: Braga M, Reddy ST, Vergnes L, Pervin S, Grijalva V, Stout D, et al. Follistatin promotes adipocyte differentiation, browning, and energy metabolism. Journal of Lipid Research. 2014;55(3):375–84.

Reference [17] also appears as references [25] and [33]. The reference is: Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.

Reference [18] also appears as reference [37]. The reference is: Arturo RR, Cecilia C, Senin LL, Landrove MO, Javier B, Ana BC, et al. FNDC5/irisin is not only a myokine but also an adipokine. Plos One. 2013;8(4):e60563.

In addition, there are typographical errors in the following references:

In reference [17], “α” incorrectly appears as “[agr].” The correct reference is: The reference is: Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.

In reference [19], “SAT-123” incorrectly appears as “SAT-123-SAT-.” The correct reference is: Triantafyllou GA, Skouvaklidou EC, Saridakis ZG, Kynigopoulos G, Dima DI, Apostolou A, et al. Circulating Follistatin and Irisin in Young, Healthy Individuals: A One-Year Prospective Cohort Study. GPCRs, Growth Factors, Tyrosine Kinases, Inhibits, Activins, and TGF Beta Superfamily (posters): Endocrine Society; 2016. p. SAT-123.

In reference [25], “brown-fat-like development” incorrectly appears as “browning.” The correct reference is: Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.

Reference [33] contains multiple errors. “Boström” incorrectly appears as “Bostrã M.” “PGC1-α-dependent” should appear as “PGC1-α-dependent.” The correct reference is: Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.

In reference [35], “ofin vitroandin vivobrown” should appear as “of in vitro and in vivo brown.” The correct reference is: Braga M, Pervin S, Norris K, Bhasin S, Singh R. Inhibition of in vitro and in vivo brown fat differentiation program by myostatin. Obesity. 2013;21(6):1180–8.


Zdroje

1. Li H, Zhang C, Liu J, Xie W, Xu W, Liang F, et al. (2019) Intraperitoneal administration of follistatin promotes adipocyte browning in high-fat diet-induced obese mice. PLoS ONE 14(7): e0220310. https://doi.org/10.1371/journal.pone.0220310 31365569


Článek vyšel v časopise

PLOS One


2019 Číslo 12
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#